Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sees Large Increase in Short Interest

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 17,200 shares, a growth of 50.9% from the September 15th total of 11,400 shares. Based on an average daily volume of 36,500 shares, the days-to-cover ratio is currently 0.5 days.

Fresenius SE & Co. KGaA Trading Up 0.2 %

OTCMKTS FSNUY traded up $0.02 on Monday, reaching $9.20. 26,699 shares of the company were exchanged, compared to its average volume of 49,784. The business’s fifty day moving average price is $9.19 and its 200 day moving average price is $8.25. The stock has a market capitalization of $20.55 billion, a P/E ratio of 12.41 and a beta of 1.05. Fresenius SE & Co. KGaA has a fifty-two week low of $6.33 and a fifty-two week high of $9.78.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.22 earnings per share for the quarter. The company had revenue of $5.83 billion for the quarter. Equities research analysts forecast that Fresenius SE & Co. KGaA will post 0.84 earnings per share for the current year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.